HEARTCARE-B (06609) spent 1.4662 million Hong Kong dollars on repurchasing 27,200 shares on January 2nd.
Xinwei Medical -B (06609) issued an announcement on January 2, 2026, that the company will spend 1.462 million Hong Kong dollars to repurchase 27,200 shares, with a repurchase price of 53.4-54.6 Hong Kong dollars per share.
HEARTCARE-B (06609) announced on January 2, 2026 that the company will spend 1.4662 million Hong Kong dollars to repurchase 27,200 shares, with a repurchase price of 53.4-54.6 Hong Kong dollars per share.
Related Articles

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


